First Trust Advisors LP Sells 212,679 Shares of Envista Holdings Corporation $NVST

First Trust Advisors LP lowered its holdings in Envista Holdings Corporation (NYSE:NVST) by 79.5% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 54,922 shares of the company’s stock after selling 212,679 shares during the period. First Trust Advisors LP’s holdings in Envista were worth $1,393,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Tudor Investment Corp ET AL purchased a new stake in Envista during the third quarter valued at about $1,664,000. Massachusetts Financial Services Co. MA lifted its position in Envista by 15.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,349,874 shares of the company’s stock valued at $72,726,000 after purchasing an additional 444,725 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Envista by 1.6% during the first quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company’s stock valued at $248,130,000 after purchasing an additional 152,488 shares during the period. Royce & Associates LP grew its holdings in shares of Envista by 11.6% in the fourth quarter. Royce & Associates LP now owns 996,147 shares of the company’s stock worth $21,626,000 after purchasing an additional 103,312 shares during the last quarter. Finally, Intech Investment Management LLC purchased a new position in shares of Envista in the fourth quarter worth $2,501,000.

Envista Price Performance

Shares of NVST opened at $28.22 on Monday. The firm has a market cap of $4.53 billion, a PE ratio of 48.65, a P/E/G ratio of 1.34 and a beta of 0.86. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. Envista Holdings Corporation has a 1-year low of $18.77 and a 1-year high of $30.42. The firm has a fifty day simple moving average of $26.03 and a two-hundred day simple moving average of $26.03.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The business had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. During the same period last year, the firm posted $0.26 earnings per share. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, equities analysts anticipate that Envista Holdings Corporation will post 1.53 EPS for the current year.

Wall Street Analyst Weigh In

NVST has been the topic of a number of research analyst reports. Robert W. Baird set a $34.00 price target on Envista in a report on Thursday. JPMorgan Chase & Co. increased their price target on shares of Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Morgan Stanley set a $23.00 price objective on Envista in a research report on Thursday. Wall Street Zen downgraded Envista from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Finally, Piper Sandler reaffirmed a “neutral” rating and issued a $28.00 price target (up from $26.00) on shares of Envista in a research report on Thursday. Six investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $29.31.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.